Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:51-58
Published online before print November 1, 2007, doi: 10.1161/CIRCRESAHA.107.157305
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/1/51    most recent
CIRCRESAHA.107.157305v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Illi, B.
Right arrow Articles by Gaetano, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Illi, B.
Right arrow Articles by Gaetano, C.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2008;102:51.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Nitric Oxide Modulates Chromatin Folding in Human Endothelial Cells via Protein Phosphatase 2A Activation and Class II Histone Deacetylases Nuclear Shuttling

Barbara Illi*, Claudio Dello Russo*, Claudia Colussi, Jessica Rosati, Michele Pallaoro, Francesco Spallotta, Dante Rotili, Sergio Valente, Gianluca Ragone, Fabio Martelli, Paolo Biglioli, Christian Steinkuhler, Paola Gallinari, Antonello Mai, Maurizio C. Capogrossi, Carlo Gaetano

From the Laboratorio di Biologia Vascolare e Terapia Genica (B.I., F.S.), Centro Cardiologico Fondazione "I. Monzino", IRCCS, Milan; Istituto di Ricerche di Biologia Molecolare I.R.B.M. P. Angeletti (C.D.R., C.S., P.G.), Via Pontina km 30 600, Pomezia, Rome; Laboratorio di Patologia Vascolare (C.C., J.R., G.R., F.M., M.C.C.), Istituto Dermopatico dell’ Immacolata-IRCCS, Rome; Università di Siena (M.P.), Siena; Dipartimento di Cardiochirurgia (P.B.), Centro Cardiologico Fondazione "I. Monzino", IRCCS, Milan; Istituto Pasteur-Fondazione Cenci Bolognetti (D.R., S.V., A.M.), Dipartimento Studi Farmaceutici Università degli Studi di Roma "La Sapienza", Rome, Italy.

Correspondence to Barbara Illi, PhD, Centro Cardiologico Fondazione "I. Monzino", Milan, Italy. E-mail b.illi{at}idi.it

Nitric oxide (NO) modulates important endothelial cell (EC) functions and gene expression by a molecular mechanism which is still poorly characterized. Here we show that in human umbilical vein ECs (HUVECs) NO inhibited serum-induced histone acetylation and enhanced histone deacetylase (HDAC) activity. By immunofluorescence and Western blot analyses it was found that NO induced class II HDAC4 and 5 nuclear shuttling and that class II HDACs selective inhibitor MC1568 rescued serum-dependent histone acetylation above control level in NO-treated HUVECs. In contrast, class I HDACs inhibitor MS27–275 had no effect, indicating a specific role for class II HDACs in NO-dependent histone deacetylation. In addition, it was found that NO ability to induce HDAC4 and HDAC5 nuclear shuttling involved the activation of the protein phosphatase 2A (PP2A). In fact, HDAC4 nuclear translocation was impaired in ECs expressing small-t antigen and exposed to NO. Finally, in cells engineered to express a HDAC4-Flag fusion protein, NO induced the formation of a macromolecular complex including HDAC4, HDAC3, HDAC5, and an active PP2A. The present results show that NO-dependent PP2A activation plays a key role in class II HDACs nuclear translocation.


Key Words: nitric oxide • endothelial cells • histone deacetylases • chromatin




This article has been cited by other articles:


Home page
FASEB J.Home page
C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, et al.
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy
FASEB J, July 1, 2009; 23(7): 2131 - 2141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Urbich, L. Rossig, D. Kaluza, M. Potente, J.-N. Boeckel, A. Knau, F. Diehl, J.-G. Geng, W.-K. Hofmann, A. M. Zeiher, et al.
HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells
Blood, May 28, 2009; 113(22): 5669 - 5679.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D. N. Dhanasekaran, L. N. Stemmle, et al.
Endothelial Nitric Oxide Synthase Inhibits G12/13 and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor: Implication in Vascular Migration
Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 217 - 224.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
V. Duong, C. Bret, L. Altucci, A. Mai, C. Duraffourd, J. Loubersac, P.-O. Harmand, S. Bonnet, S. Valente, T. Maudelonde, et al.
Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells
Mol. Cancer Res., December 1, 2008; 6(12): 1908 - 1919.
[Abstract] [Full Text] [PDF]